Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Cardiovascular Diagnostics: World Market Trends and Analysis

Published by: PJB Publications USA Inc.

Published: Mar. 1, 2003 - 195 Pages


Table of Contents


1 Executive Summary

    1.1 Overview

    1.2 Scope and Objectives of Report

    1.3 Methodology of Investigation

    1.4 Limitations of the Research

    1.5 Market Summary



2 Overview of Cardiovascular Diagnostics

    2.1 Introduction

    2.1.1 Diagnostics in Non-Acute Care

    2.1.2 Diagnostics in Acute Care

    2.1.3 Assessing Disease Risk and Severity

    2.2 Pros and Cons of Early Diagnosis



3 Market Dynamics in Cardiovascular Diagnostics

    3.1 Overview

    3.2 Market Population Trends

    3.3 Cardiovascular Disease Demographics

    3.3.1 North America

    3.3.2 Europe

    3.3.3 China

    3.3.4 Japan

    3.3.5 Rest of World

    3.4 Specific Cardiovascular Disease Statistics

    3.4.1 Hypertension

    3.4.2 Coronary Artery Disease

    3.4.3 Chronic Heart Failure

    3.4.4 Angina

    3.4.5 Deep Vein Thrombosis/Pulmonary Embolism

    3.4.6 Stroke

    3.4.7 Diabetes and Pre-Diabetes

    3.5 Managed Bioinformatics and Risk Assessment

    3.6 Patient Outcomes and Reimbursement Issues



4 Cardiovascular Diagnostic Technologies

    4.1 In Vivo and Imaging Test Modalities

    4.1.1 In Vivo Imaging and the Cardiovascular Disease Process

    4.1.2 Advanced Cardiovascular Imaging Technologies

    4.2 Point-of-Care (POC) Cardiovascular Disease Testing

    4.2.1 POC Testing in Patient Care and Retail Sites

    4.2.2 POC Testing in the Hospital Setting

    4.2.3 At-Home POC Testing and Telemedicine

    4.3 Genomics and Traditional Diagnostics



5 World Market Analysis

    5.1 Introduction

    5.2 Market Overvie

    5.2.1 Cardiovascular Disease Markers

    5.2.2 Acute Myocardial Infarction Testing

    5.2.3 Company Overview

    5.3 Total World Market Size and Forecast

    5.4 Cardiac Enzymes

    5.5 Lipid Markers

    5.6 D-dimer Testing.

    5.7 Homocysteine Testing

    5.8 Genetic Markers

    5.9 Coagulation Fa

    5.10 Inflammation Markers

    5.11 Special Enzymes and Protein Markers



6 Innovator Company Briefs

    6.1 AGEN Biomedical Ltd.

    6.2 Atherotech, Inc.

    6.3 Axis-Shield Diagnostics Ltd.

    6.4 Biosite Inc

    6.5 Cholestech Corp.

    6.6 Competitive Technologies, Inc

    6.7 CompuCyte C 131

    6.8 Corgenix Medical Corp.

    6.9 Dade Behring 135

    6.10 diaDexus, Inc. 137

    6.11 HomMed LLC

    6.12 IGEN International, Inc.

    6.13 Interleukin Genetics Inc.

    6.14 IntraCellular Diagnostics, Inc

    6.15 Ischemia Technologies, Inc.

    6.16 Lifestream Technologies, Inc.

    6.17 LipoScience, Inc. (formerly LipoMed, Inc.)

    6.18 MetriGenix, Inc.

    6.19 Myriad Genetics, Inc.

    6.20 Nanogen, Inc.. 157

    6.21 Roche Diag 159

    6.22 Spectral Diagnostics Inc

    6.23 SYN X Pharma Inc.

    6.24 Third Wave Technologies, Inc.



7 Company Directory


Appendix A: Selected Cardiovascular In Vivo Diagnostic Products, 2002


Appendix B: Selected Cardiovascular In Vitro Diagnostic Products, 2002



List of Tables


  • Table 4-1 In Vivo Cardiovascular Diagnostic Techniques
  • Table 5-1 World Cardiovascular In Vitro Diagnostics Sales and Growth 2001, 2006
  • Table 5-2 World Cardiovascular In Vitro Diagnostics Market Shares by Test Category 2001
  • Table 5-3 World Cardiovascular In Vitro Diagnostics Market Shares by Test Category 2006
  • Table 5-4 World Cardiovascular In Vitro Diagnostics Sales and Growth for Cardiac Enzymes 2001, 2006
  • Table 5-5 World Cardiovascular In Vitro Diagnostics Sales and Growth for Lipid Markers 2001, 2006
  • Table 5-6 World Cardiovascular In Vitro Diagnostics Sales and Growth for D-dimer Tests 2001, 2006
  • Table 5-7 World Cardiovascular In Vitro Diagnostics Sales and Growth for Homocysteine Tests 2001, 2006
  • Table 5-8 World Cardiovascular In Vitro Diagnostics Sales and Growth for Genetic Markers 2001, 2006
  • Table 5-9 World Cardiovascular In Vitro Diagnostics Sales and Growth for Coagulation Factors 2001, 2006
  • Table 5-10 World Cardiovascular In Vitro Diagnostics Sales and Growth for Inflammation Markers 2001, 2006
  • Table 5-11 World Cardiovascular In Vitro Diagnostics Sales and Growth for Special Enzymes and Protein Markers 2001, 2006
  • Figure 5-1 World Cardiovascular In Vitro Diagnostics Sales and Growth 2001, 2006
  • Figure 5-2 World Cardiovascular In Vitro Diagnostics Market Shares by Test Category 2001
  • Figure 5-3 World Cardiovascular In Vitro Diagnostics Market Shares by Test Category 2006
  • Figure 5-4 World Cardiovascular In Vitro Diagnostics Sales for Cardiac Enzymes 2001, 2006
  • Figure 5-5 World Cardiovascular In Vitro Diagnostics Sales for Lipid Markers 2001, 2006
  • Figure 5-6 World Cardiovascular In Vitro Diagnostics Sales for D-dimer Tests 2001, 2006
  • Figure 5-7 World Cardiovascular In Vitro Diagnostics Sales for Homocysteine Tests 2001, 2006
  • Figure 5-8 World Cardiovascular In Vitro Diagnostics Sales for Genetic Markers 2001, 2006
  • Figure 5-9 World Cardiovascular In Vitro Diagnostics Sales for Coagulation Factors 2001, 2006
  • Figure 5-10 World Cardiovascular In Vitro Diagnostics Sales for Inflammation Markers 2001, 2006
  • Figure 5-11 World Cardiovascular In Vitro Diagnostics Sales for Special Enzymes and Protein Markers 2001, 2006


Abstract

With cardiovascular disease still the leading cause of morbidity and mortality worldwide, the challenge now is to develop increasingly sensitive diagnostic modalities, especially in vitro diagnostic tests, that can solve the problem of early diagnosis or detection of predisposing factors. Key drivers are forecast to boost the market for cardiac diagnostics from $14 billion in 2001 to $2.2 billion in 2006, 12% per year.

Theta’s report presents diagnostic modalities for the detection of cardiovascular disease throughout the continuum of disease progression, including congestive heart failure, unstable angina, myocardial infarction, stroke, and other manifestations of cardiovascular disease. The emphasis is on in vitro diagnostic tests, primarily because this is where the major market opportunities lie.

The report covers market trends and issues concerning:

  • In vitro diagnostic biomarkers and genetic indicators
  • Point-of-care testing
  • Bioinformatics
  • In vivo diagnostics

For in vitro diagnostics, this report provides information on companies and technologies that will challenge the status quo of traditional cardiovascular disease testing. Specific areas covered are:

  • Lipid markers
  • Inflammation markers
  • Enzymes and proteins
  • AMI enzymes
  • Procoagulation and thrombolytic markers
  • Genetic markers
  • Diabetes testing

Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.



Get Full Details About This Report >>

US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 200,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009